Description
  
  
$5.6 million awarded to Kaiser Permanente researcher to study treatments for type 2 diabetes$5.6 million awarded to Kaiser Permanente researcher to study treatments for type 2 diabetes

A research team led by Romain S. Neugebauer, PhD, an investigator at the Kaiser Permanente Northern California Division of Research, and Patrick O’Connor, MD, an investigator at HealthPartners Institute, received a $5.6 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to study the benefits — and potential harms — on heart health of the second-line medications used to treat type 2 diabetes.​

8/7/2021
  
Food banks tackling diabetes? Feeding America releases pilot intervention resultsFood banks tackling diabetes  Feeding America releases pilot intervention results

Food banks can improve food security, dietary intake and health status for vulnerable individuals, such as those with diabetes Type 2, according to a new report from Feeding America.​

8/4/2021
  
Depressed pregnant women more likely to eat poorer diets, Kaiser Permanente analysis findsDepressed pregnant women more likely to eat poorer diets, Kaiser Permanente analysis finds

Pregnant women with depression were more likely to eat poor diets with a higher intake of empty calories and lower intake of greens, beans, and fruit, according to an analysis of 1,160 adult pregnant women who were treated at Kaiser Permanente Northern California.​

8/3/2021
  
Heart Risks Are Similar With Human and Analogue Insulin, at Least InitiallyHeart Risks Are Similar With Human and Analogue Insulin, at Least Initially
People with type 2 diabetes who start taking insulin to manage their blood sugar may have a similarly low risk of developing or dying from cardiovascular problems regardless of the type of insulin they use, a new study suggests.​
8/1/2021



​​​​​​